Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FQQ1A
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $125,278
Award facts
- Contract value 100% obligated
- $125,278.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $125,278.12 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on November 14, 2025, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. RINVOQ (upadacitinib) is a prescription medication used to treat rheumatoid arthritis and other inflammatory conditions, representing part of AmerisourceBergen's extensive pharmaceutical supply portfolio for federal military and healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a prime vendor for global pharmaceutical support, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and other federal health systems worldwide. The company's demonstrated capability to compete successfully for federal pharmaceutical procurement and its established infrastructure as a critical healthcare solutions provider position it as a key vendor within the DLA's medical supply chain operations.
Quick answers
Who was awarded contract SPE2DR26FQQ1A?
SPE2DR26FQQ1A was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26FQQ1A worth?
The government has obligated $125,278 on SPE2DR26FQQ1A.
Is contract SPE2DR26FQQ1A an order under another contract?
Yes. SPE2DR26FQQ1A is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ1A competed?
The extent of competition for SPE2DR26FQQ1A was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award